Model-Informed Dose Selection for Xentuzumab, a Dual Insulin-Like Growth Factor-I/II—Neutralizing Antibody
Keywords:
Insulin-like growth factor (IGF)
IgG1 monoclonal antibody
Binding proteins (IGFBPs)
Xentuzumab
IGFBP-3
IGF-I
IGF-II
Citation:
Fernández-de-Trocóniz, J.I. (José Ignacio); Parra-Guillen, Z.P. (Zinnia Patricia). "Model-Informed Dose Selection for Xentuzumab, a Dual Insulin-Like Growth Factor-I/II—Neutralizing Antibody". Clinical Pharmacology & Therapeutics. 107 (3), 2019, 597 - 606
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.